Blueprint Medicines Corp (BPMC)
89.50 +1.02 (+1.15%) 04/30/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 89.50 unch (unch) 16:13 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | BPMC | ADMA | NUVL | ||
| Company | Blueprint Medicines Corp | Adma Biologics | Nuvalent Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 88.21 | 23.27 | 75.70 | ||
| High | 89.99 | 24.09 | 77.24 | ||
| Low | 87.03 | 23.18 | 75.03 | ||
| Last | 89.50 | 23.80 | 76.75 | ||
| Change | +1.02 | -0.31 | +0.88 | ||
| % Change | +1.15% | -1.29% | +1.16% | ||
| Volume | 1,106,500 | 2,817,600 | 604,600 | ||
| 20-Day Average Volume | 1,077,815 | 4,077,695 | 639,125 | ||
| Previous Close | 88.48 | 24.11 | 75.87 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 84.29 | 20.82 | 69.66 | ||
| 20-Day Raw Stochastic | 94.87% | 79.59% | 97.74% | ||
| 20-Day Relative Strength | 53.06% | 62.25% | 56.12% | ||
| Weighted Alpha | -20.08 | +156.41 | -0.47 | ||
| Today's Opinion | 72% Sell | 100% Buy | 56% Sell | ||
| Previous Opinion | 72% Sell | 100% Buy | 56% Sell | ||
| Last Month's Opinion | 56% Sell | 72% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.30% since 04/23/25 | +9.53% since 04/23/25 | +5.56% since 04/23/25 | ||
| Low | 84.25 on 04/25/25 | 21.61 on 04/25/25 | 71.60 on 04/24/25 | ||
| High | 89.99 on 04/30/25 | 25.67 on 04/28/25 | 77.24 on 04/30/25 | ||
| 1-Month | |||||
| %Chg | +0.88% since 03/28/25 | +17.47% since 03/28/25 | +5.07% since 03/28/25 | ||
| Low | 73.04 on 04/09/25 | 16.51 on 04/07/25 | 55.53 on 04/09/25 | ||
| High | 90.39 on 04/02/25 | 25.67 on 04/28/25 | 77.24 on 04/30/25 | ||
| 3-Month | |||||
| %Chg | -21.53% since 01/30/25 | +47.83% since 01/30/25 | -12.54% since 01/30/25 | ||
| Low | 73.04 on 04/09/25 | 13.50 on 03/04/25 | 55.53 on 04/09/25 | ||
| High | 116.23 on 01/31/25 | 25.67 on 04/28/25 | 91.50 on 02/06/25 | ||
| 6-Month | |||||
| %Chg | +0.29% since 10/30/24 | +40.33% since 10/30/24 | -14.95% since 10/30/24 | ||
| Low | 73.04 on 04/09/25 | 13.50 on 03/04/25 | 55.53 on 04/09/25 | ||
| High | 118.25 on 01/27/25 | 25.67 on 04/28/25 | 97.65 on 11/25/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,654,403 | 5,728,898 | 5,432,140 | ||
| Shares Outstanding, K | 63,906 | 237,615 | 71,598 | ||
| Annual Sales | 508,820,000 | 426,450,000 | 0 | ||
| Annual Net Income | -67,090,000 | 197,670,000 | -260,760,000 | ||
| Last Quarter Sales | 146,370,000 | 117,550,000 | 0 | ||
| Last Quarter Net Income | -49,960,000 | 111,900,000 | -74,760,000 | ||
| 60-Month Beta | 0.75 | 0.53 | 1.43 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.79 on 02/13/25 | 0.14 on 03/03/25 | -1.05 on 02/27/25 | ||
| Latest Earnings Date | 05/01/25 | 05/08/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 49.02 | 0.00 | ||